Sanofi (SNYNF) shareholders
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Ownership
Who owns Sanofi's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 72,127,649 | 5.80% | 13G (passive) amendment | Mar 31, 2025 |
| Amundi Joint filing with Amundi Asset Management (5.70%) | 68,832,052 | 5.70% | 13G (passive) amendment | Sep 30, 2026 |
| Amundi Asset Management Joint filing with Amundi (5.65%) | 68,651,904 | 5.65% | 13G (passive) amendment | Jun 30, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
42.7
At 0M shares a day
Change since last report
-20.9%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sanofi's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?